Autopsy report · NCT04947917
Axillary Lymph Node Tattoo Marking Study
Cause of deathFunding or business
“Institutional standard of care regarding axillary management changed. Decision was made to close the study early.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 3 months before it stopped.
- 10 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Dana-Farber Cancer Institute
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer; Lymph Node Metastases
- Interventions
- SpotTM Tattoo Ink
- Participants
- 10
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.